- Introduction: Private Equity, IPOs, Price to Sales & the Passive Patsies Revisited
- The Abundance of the Absurd in the World of Index Rebalancing
- The Consequences of Expensive Additions
- Conclusion
- Exhibits
- Appendix: Fundamentals of Expensive Additions
Introduction: Private Equity, IPOs, Price to Sales & the Passive Patsies Revisited
Starting in December 2018, Kailash published a series of interconnected research pieces tracking what we believe is unprecedented levels of group-think and the associated risks to investors. The papers most relevant to this research are listed below and document the following:
- Private vs. Public Markets: Allocators’ record herding into private equity and the myriad investment challenges faced by the space
- Better a Seller than a Buyer Be?: With public market valuations today equivalent to the 2000 peak this creates an appealing time for private equity firms to begin dumping their portfolio firms and possibly expose index investors to a good deal of risk
- IPOs and the Passive Patsies: How the stratospheric valuations of firms being brought public by private equity today could damage unwitting index investors due to these firms’ long histories of generating ever larger losses
- When the Top Decile is the Bottom of the Barrel: How the most expensive group of stocks based on Price to Sales (P/S) looked nearly as bad if not worse than any time in history and that subsequent outcomes in periods similar to today had been disastrous
Get our White Papers direct to your inbox: SUBSCRIBE
Kailash believes that the confluence of the above events and the simple mechanics of index rebalancing have rarely if ever been more dangerous for index investors.
Like private equity, index investing is benefitting from a frenzied bout of investor mania and Kailash believes investors in both would be wise to revisit their investments in these vehicles with a healthy dose of common sense.1
Disclaimer
The information, data, analyses, and opinions presented herein (a) do not constitute investment advice, (b) are provided solely for informational purposes and therefore are not, individually or collectively, an offer to buy or sell a security, (c) are not warranted to be correct, complete or accurate, and (d) are subject to change without notice. Kailash Capital Research, LLC and its affiliates (collectively, “Kailash Capital Research, LLC ”) shall not be responsible for any trading decisions, damages or other losses resulting from, or related to, the information, data, analyses or opinions or their use. The information herein may not be reproduced or retransmitted in any manner without the prior written consent of Kailash Capital Research, LLC . In preparing the information, data, analyses, and opinions presented herein, Kailash Capital Research, LLC has obtained data, statistics, and information from sources it believes to be reliable. Kailash Capital Research, LLC , however, does not perform an audit or seeks independent verification of any of the data, statistics, and information it receives. Kailash Capital Research, LLC and its affiliates do not provide tax, legal, or accounting advice. This material has been prepared for informational purposes only and is not intended to provide, and should not be relied on for tax, legal, or accounting advice. You should consult your tax, legal, and accounting advisors before engaging in any transaction. © 2021 Kailash Capital Research, LLC – All rights reserved.
Nothing herein shall limit or restrict the right of affiliates of Kailash Capital Research, LLC to perform investment management or advisory services for any other persons or entities. Furthermore, nothing herein shall limit or restrict affiliates of Kailash Capital Research, LLC from buying, selling or trading securities or other investments for their own accounts or for the accounts of their clients. Affiliates of Kailash Capital Research, LLC may at any time have, acquire, increase, decrease or dispose of the securities or other investments referenced in this publication. Kailash Capital Research, LLC shall have no obligation to recommend securities or investments in this publication as result of its affiliates’ investment activities for their own accounts or for the accounts of their clients.
October 12, 2019 |
| Authors: Matthew Malgari, Nathan Przybylo, Dr. Sanjeev Bhojraj and John Durkin
October 12, 2019
Authors: Matthew Malgari, Nathan Przybylo, Dr. Sanjeev Bhojraj and John Durkin